Impact of the new reimbursement for secondary fracture prevention on inter-hospital variation in osteoporosis treatment for hip fracture patients: A nationwide analysis using DPC data

This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. PURPOSE: This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. METHODS: Using Diagnosis Procedure Combination data (April 2020-March 2024) from hospitals participating in the Quality Indicator/Improvement Project, we categorized hospitals as introduced or non-introduced. Inter-hospital variation was quantified using median odds ratios from a logistic mixed-effects model, and generalized estimating equations were used to examine hospital-level factors influencing the management fee's effectiveness. RESULTS: Among 168 hospitals (143 introduced, 25 non-introduced) and 76,111 patients, the prescription proportion in introduced hospitals increased from 30.9% to 71.8%, whereas it remained at approximately 20% in non-introduced hospitals. The median odds ratio in introduced hospitals increased significantly, from 2.66 (95% confidence interval 2.39-3.03) to 3.39 (2.96-4.00), indicating increased inter-hospital variation. The management fee's effectiveness was significantly lower in rural and private hospitals and those with low surgical volumes. CONCLUSION: The management fee functioned as an incentive for secondary fracture prevention, but its impact was uneven and increased inter-hospital disparities. Achieving equitable secondary fracture prevention may require a comprehensive approach that provides not only uniform financial incentives but also targeted support for hospitals with limited resources.

Authors

Institutions

Publication Details

Journal
Osteoporosis International
Published
2026-11-14
DOI
https://doi.org/10.1007/s00198-026-08308-8
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of the new reimbursement for secondary fracture prevention on inter-hospital variation in osteoporosis treatment for hip fracture patients: A nationwide analysis using DPC data

Susumu Kunisawa, Gaku Gondo, Yuichi Imanaka
3 links
Osteoporosis International
Bone health and osteoporosis research
article

Impact of the new reimbursement for secondary fracture prevention on inter-hospital variation in osteoporosis treatment for hip fracture patients: A nationwide analysis using DPC data

Susumu Kunisawa, Gaku Gondo, Yuichi Imanaka
article en

Abstract

This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. PURPOSE: This study evaluated how the Secondary Fracture Prevention Continuity Management Fee (hereinafter, "the management fee"), established in Japan in April 2022, affected inter-hospital variation in osteoporosis medication prescription after hip fracture, and which hospital factors influenced its effectiveness. METHODS: Using Diagnosis Procedure Combination data (April 2020-March 2024) from hospitals participating in the Quality Indicator/Improvement Project, we categorized hospitals as introduced or non-introduced. Inter-hospital variation was quantified using median odds ratios from a logistic mixed-effects model, and generalized estimating equations were used to examine hospital-level factors influencing the management fee's effectiveness. RESULTS: Among 168 hospitals (143 introduced, 25 non-introduced) and 76,111 patients, the prescription proportion in introduced hospitals increased from 30.9% to 71.8%, whereas it remained at approximately 20% in non-introduced hospitals. The median odds ratio in introduced hospitals increased significantly, from 2.66 (95% confidence interval 2.39-3.03) to 3.39 (2.96-4.00), indicating increased inter-hospital variation. The management fee's effectiveness was significantly lower in rural and private hospitals and those with low surgical volumes. CONCLUSION: The management fee functioned as an incentive for secondary fracture prevention, but its impact was uneven and increased inter-hospital disparities. Achieving equitable secondary fracture prevention may require a comprehensive approach that provides not only uniform financial incentives but also targeted support for hospitals with limited resources.

Osteoporosis International
Kyoto University (JP), Center for Health Security, Graduate School of Medicine, Kyoto University (JP)
Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science
Good health and well-being
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon